Cytodyn Inc (CYDY)

[misiu143]

Yes , what we are hearing , for FDA efficacy is the most important . and they will not look at some subgroup.

So 82% in leronlimab CD12 study , 82% in mortality benefit ABOVE any other drug in a dying , critical patients was not even looked at..

So why this subgroup pf patients , patient below 5 years old , patients at VERY low risk of dying , or developing severe sickness , had this vaccine approved for them ..after study showing VERY low efficacy

https://www.zerohedge.com/covid-19/pfizer-funded-study-shows-poor-effectiveness-covid-19-vaccine-young-children

Ahhh , because vaccine MUST be approved , so the BP will make billions every years , and they giving hundreds of thousands to FDA yearly ..

Oh yes , I forgot ....

https://rumble.com/vv1w9x-project-veritas-reveals-fda-exec-biden-wants-to-inoculate-as-many-people-as.html


All imo.

GLTA longs.